Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee06c38b8ca03c707802a99aaba07d7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 |
filingDate |
2021-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0505265dd65e45f873b073a105b0700 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fd86538836aed487c390b4b9606cc7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50f0bbf7916cd3a7526b62aae6fe5b0b |
publicationDate |
2022-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022104289-A1 |
titleOfInvention |
Use of pharmaceutical doses of niacin, or an analog thereof, for the regression or reversal of fibrosis and/or liver cirrhosis |
abstract |
The disclosure provides for the use of high-dose (pharmacologic) niacin, or a niacin analog thereof, for the treatment or regression of fibrosis or liver cirrhosis in a subject in need thereof. |
priorityDate |
2020-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |